Literature DB >> 12957107

Ensuring ethical drug promotion--whose responsibility?

Jonathan D Quick, Hans V Hogerzeil, Lembit Rägo, Valerio Reggi, Kees de Joncheere.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Substances：

Year:  2003        PMID： 12957107     DOI： 10.1016/S0140-6736(03)14217-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Direct to consumer advertising.

Authors:  Peter R Mansfield; Barbara Mintzes; Dee Richards; Les Toop
Journal:  BMJ       Date:  2005-01-01

2.  Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.

Authors:  T Walley; P Folino-Gallo; P Stephens; E Van Ganse
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

3.  Disease mongering in drug promotion: do governments have a regulatory role?

Authors:  Barbara Mintzes
Journal:  PLoS Med       Date:  2006-04-11       Impact factor: 11.069

4.  Compliance of disease awareness campaigns in printed Dutch media with national and international regulatory guidelines.

Authors:  Teresa Leonardo Alves; Auramarina F Martins de Freitas; Martine E C van Eijk; Aukje K Mantel-Teeuwisse
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.